MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Financial income (loss),net (note 17)$89,454K (4013.12%↑ Y/Y)Other income, net$958K Revenues$2,000K Income (loss) beforetax expenses$75,324K (573.14%↑ Y/Y)Operating loss-$15,088K (-18.05%↓ Y/Y)Gross profit$13K Cost of revenue$1,987K Net income (loss)$64,016K Non-controlling interests-$34K Tax expenses$11,308K (255.26%↑ Y/Y)General andadministrative expenses$8,720K (35.05%↑ Y/Y)Research and developmentexpenses$6,381K (0.90%↑ Y/Y)Companys stockholders$64,050K (435.29%↑ Y/Y)
Income Statement
source: myfinsight.com

ORAMED PHARMACEUTICALS INC. (ORMP)

ORAMED PHARMACEUTICALS INC. (ORMP)